Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn | 317.00 Mn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn | 592.00 Mn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn | -1.80 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn | 206.70 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn | 1.13 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 439.70 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn | 30.80 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn | 449.00 Mn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - | 21.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.93 Mn |
| Mar 31, 2026 | 16.17 Mn |
| Dec 31, 2025 | 15.39 Mn |
| Sep 30, 2025 | 16.17 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | 17.83 Mn |
| Jun 30, 2024 | 21.65 Mn |
| Mar 31, 2024 | 57.76 Mn |
| Dec 31, 2023 | 52.24 Mn |
| Sep 30, 2023 | 48.72 Mn |
| Jun 30, 2023 | 43.39 Mn |
| Mar 31, 2023 | 44.01 Mn |
| Dec 31, 2022 | 40.84 Mn |
| Sep 30, 2022 | 29.94 Mn |
| Jun 30, 2022 | 29.99 Mn |
| Mar 31, 2022 | 26.35 Mn |
| Dec 31, 2021 | 14.92 Mn |
| Sep 30, 2021 | 10.35 Mn |